{"id":"W4387467433","doi":"10.1007/978-981-99-2341-0_5","title":"Adjuvant Treatment and Follow-Up of Clinically Localized Renal Cell Carcinoma","year":2023,"lang":"en","type":"book-chapter","venue":"","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Renal cell carcinoma; Oncology; Nomogram; Adjuvant; Internal medicine; Systemic therapy; Adjuvant therapy; Angiogenesis inhibitor; Kidney cancer; Tyrosine-kinase inhibitor; Disease; Pazopanib; Angiogenesis; Cancer; Sunitinib","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000136078,0.00009628991,0.0001329108,0.0001849409,0.0001219843,0.0002192902,0.0002399775,0.000182504,0.00428339],"category_scores_gemma":[0.0003300633,0.00004881745,0.0001285425,0.0002044217,0.0001007938,0.0001661032,0.0001302725,0.0004638945,0.0007994827],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002821632,"about_ca_system_score_gemma":0.0003241363,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001979322,"about_ca_topic_score_gemma":0.007155962,"domain_scores_codex":[0.9999707,0.000008608138,0.000001926613,0.000003202656,0.00001179226,0.000003746056],"domain_scores_gemma":[0.9999492,0.00003554116,0.000003972509,0.000002424243,0.000004538327,0.000004334192],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0001396885,0.0001875515,0.003596493,0.0002322014,0.000009717549,0.001671221,0.000218729,0.0009490958,0.003043073,0.01240186,0.06084057,0.9167098],"study_design_scores_gemma":[0.00002794493,0.0004260152,0.0532682,0.0008057193,0.00005241523,0.01995826,0.0002699897,0.001709443,0.003200423,0.01418878,0.9060723,0.00002060196],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"other","genre_gemma":"other","genre_scores_codex":[0.0585692,0.2867662,0.01717683,0.008741016,0.002918916,0.00008476309,0.0008479555,0.0002623669,0.6246327],"genre_scores_gemma":[0.2964271,0.1609813,0.0105227,0.003199216,0.002171298,0.0001147532,0.0009848456,0.000115434,0.5254833],"genre_candidate":"other","genre_consensus":"other","teacher_disagreement_score":0.00428339,"threshold_uncertainty_score":0.01432937,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05375513750173298,"score_gpt":0.2819232210277279,"score_spread":0.228168083525995,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}